Search
Galápagos CEO Paul Stoffels on the company's $3.8B cash balance and decentralized CAR-T program
Paul Stoffels describes how his company's decentralized CAR-T process is designed to have a shorter 'brain-to-vein' time.
Jan 9, 2024
top of page
Search
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
.png){kind=logo}
Sponsor Spotlight
Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.
bottom of page